Pharmaceutical substance:
Butamirate citrate
Pharmaceutical product:
Acidi salicylici unguentum 1% cum etheroleo lavandulae
Technical notes for pharmaceutical substances and products submitted for public inquiry (attached text)
The draft concerns the following active pharmaceutical ingredient (API):
Butamirate citrate
The draft concerns the following pharmaceutical product:
Acidi salicylici unguentum 1% cum etheroleo lavandulae
The draft concerns the following API:
Butamirate citrate
The draft concerns the following pharmaceutical product:
Acidi salicylici unguentum 1% cum etheroleo lavandulae
Keywords: active pharmaceutical ingredient, Butamirate citrate, pharmaceutical product, Acidi salicylici unguentum, etheroleo lavandulae
Part of the draft was previously notified under 2017/124/CZ. However, on 27 November 2017, the notification procedure was stopped due to withdrawal by the Member State. Significant changes were to be made to the draft, which have now been incorporated.